Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
$1B |
| 2 |
Netflix
NFLX
|
$721M |
| 3 |
Apple
AAPL
|
$468M |
| 4 |
UnitedHealth
UNH
|
$422M |
| 5 |
GE Vernova
GEV
|
$376M |
Top Sells
| 1 |
Broadcom
AVGO
|
$673M |
| 2 |
Robinhood
HOOD
|
$481M |
| 3 |
Meta Platforms (Facebook)
META
|
$433M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$402M |
| 5 |
Palantir
PLTR
|
$380M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
NRG Energy
NRG
$28.6B
| $91.6M | 0.12% |
570,316
+449,500
| +372% | +$72.2M |
|
177
CAVA Group
CAVA
$7.65B
| $91.5M | 0.12% |
1,085,956
+167,706
| +18% | +$14.1M |
|
178
Las Vegas Sands
LVS
$37.8B
| $91.2M | 0.12% |
2,095,079
-359,300
| -15% | -$15.6M |
|
179
AstraZeneca
AZN
$254B
| $91.1M | 0.12% |
1,303,773
+1,004,573
| +336% | +$70.2M |
|
180
Dollar Tree
DLTR
$20.4B
| $90.4M | 0.12% |
912,803
+428,100
| +88% | +$42.4M |
|
181
Clear Secure
YOU
$3.41B
| $89.4M | 0.12% |
3,219,359
+395,200
| +14% | +$11M |
|
182
Brown & Brown
BRO
$31.5B
| $89M | 0.12% |
803,112
+630,112
| +364% | +$69.9M |
|
183
Campbell Soup
CPB
$9.74B
| $88.4M | 0.12% |
2,884,827
+1,022,600
| +55% | +$31.3M |
|
184
Zscaler
ZS
$41.8B
| $87.6M | 0.12% |
278,900
+267,018
| +2,247% | +$83.8M |
|
185
Pinterest
PINS
$25.2B
| $87.5M | 0.12% |
2,438,786
-774,876
| -24% | -$27.8M |
|
186
Gartner
IT
$17.9B
| $86.5M | 0.12% |
214,009
+126,200
| +144% | +$51M |
|
|
BPMC
187
DELISTED
Blueprint Medicines
BPMC
| $86.5M | 0.12% |
+674,500
| New | +$86.5M |
|
188
GSK
GSK
$79.8B
| $86.4M | 0.12% |
2,250,853
+268,700
| +14% | +$10.3M |
|
189
Seagate
STX
$39.1B
| $84.5M | 0.11% |
585,293
+513,300
| +713% | +$74.1M |
|
190
UBS Group
UBS
$128B
| $83.8M | 0.11% |
2,477,891
+1,386,500
| +127% | +$46.9M |
|
191
Enova International
ENVA
$3.09B
| $83.7M | 0.11% |
750,537
-23,657
| -3% | -$2.64M |
|
192
Tapestry
TPR
$22B
| $83.5M | 0.11% |
951,000
-450,000
| -32% | -$39.5M |
|
193
Natera
NTRA
$22.9B
| $83.4M | 0.11% |
493,800
+146,100
| +42% | +$24.7M |
|
194
Winmark
WINA
$1.7B
| $83.3M | 0.11% |
220,496
+44,965
| +26% | +$17M |
|
195
Morningstar
MORN
$10.9B
| $83.2M | 0.11% |
265,170
+29,900
| +13% | +$9.39M |
|
196
AB InBev
BUD
$116B
| $82.5M | 0.11% |
1,201,200
+279,100
| +30% | +$19.2M |
|
197
EQT Corp
EQT
$32.3B
| $82.4M | 0.11% |
1,412,365
+871,000
| +161% | +$50.8M |
|
198
IAMGOLD
IAG
$5.44B
| $82.2M | 0.11% |
11,189,766
-2,738,530
| -20% | -$20.1M |
|
199
Edwards Lifesciences
EW
$47.5B
| $81.4M | 0.11% |
1,040,386
+33,786
| +3% | +$2.64M |
|
200
Take-Two Interactive
TTWO
$44.4B
| $81.2M | 0.11% |
+334,239
| New | +$81.2M |
|